Europe Blood Banking Market Potential Discussed in New VPG Report Published at Marketpublishers.Com

16 Mar 2012 • by Natalie Aster

LONDON – Owing to a number of factors like more stringent regulations; improvements in diagnostic technologies, IT, system engineering and automation; and intensifying competition, the blood banking market is poised to undergo considerable changes in the next five years. All these upcoming transformations in the marketplace are expected to provide amazing opportunities for new instruments and reagent systems, as well as auxiliary products, like specimen preparation devices, controls, calibrators, and innovative IT applications.

New research report “The 2012 European Blood Banking Market: France, Germany, Italy, Spain, UK - Emerging Opportunities and Business Expansion Strategies” prepared by Venture Planning Group (VPG) explores future marketing and technological trends in Europe’s five major markets – France, Germany, Italy, Spain and the UK; provides estimates of the test volume, instrument placements and sales; compares features of major automated and semi-automated analyzers; profiles top and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next five years.

Companies mentioned in the report include: Abbott, Beckman Coulter, Becton Dickinson, Biokit, BioMerieux, Bio-Rad, Diagast, DiaSorin, Fujirebio, Gen-Probe, Grifols, Immucor, Innogenetics, Ortho-Clinical Diagnostics, Orchid CellMark, Novartis Diagnostics, Proteome Sciences, Roche, Siemens, and Tecan.

Report Details:

The 2012 European Blood Banking Market: France, Germany, Italy, Spain, UK - Emerging Opportunities and Business Expansion Strategies
Published: March, 2012
Pages: 600
Price: US$ 18.500,00

Reports Examining Other European In Vitro Diagnostics Markets are Also Available:

• The 2012 European Coagulation Testing Market: France, Germany, Italy, Spain, UK - Emerging Opportunities and Business Expansion Strategies
• The 2012 European Infectious Disease Testing Market: France, Germany, Italy, Spain, UK - Emerging Opportunities and Business Expansion Strategies
• The 2012 European Cancer Diagnostics Market: France, Germany, Italy, Spain, UK- Emerging Opportunities and Business Expansion Strategies
• The 2012 European Molecular Diagnostics Market: France, Germany, Italy, Spain, UK - Emerging Opportunities and Business Expansion Strategies

More new research reports by the publisher can be found at VPG page.

Contacts

MarketPublishers, Ltd.
Tanya Rezler
Tel: +44 208 144 6009
Fax: +44 207 900 3970
[email protected]
MarketPublishers.com